Evaluating the risk of underdiagnosis of invasive breast cancer in needle biopsy-diagnosed ductal carcinoma in situ eligible for radiofrequency ablation
Our findings highlight the risk of underdiagnosing invasive breast cancer in patients undergoing RFA for needle biopsy-diagnosed DCIS. It is crucial to acknowledge the potential for undertreatment when considering RFA as a treatment option.
Authors
- Ai Amioka (ORCID: https://orcid.org/0000-0002-9507-6651)
- Koji Arihiro (ORCID: https://orcid.org/0000-0001-9544-4832)
- Morihito Okada (ORCID: https://orcid.org/0000-0002-1589-9114)
- Shinsuke Sasada (ORCID: https://orcid.org/0000-0003-1623-869X)
- Haruka Ikejiri (ORCID: https://orcid.org/0000-0002-0869-3484)
- Emiko Hiraoka (ORCID: https://orcid.org/0000-0001-6834-7631)
- Kanako Suzuki (ORCID: https://orcid.org/0000-0002-9199-0104)
- Hideo Shigematsu (ORCID: https://orcid.org/0000-0001-9393-9655)
- Mutsumi Fujimoto (ORCID: https://orcid.org/0000-0002-5081-2854)
Institutions
- Hiroshima University (JP)
- Hiroshima University Hospital (JP)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1186/s12957-025-03697-2
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00